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Haptens such as trinitrophenyl (TNP),~ fluorescein isothiocyanate (FITC), and 
N-iodoacetyl-N'-(5-sulfonic-l-napthyl)ethylenediamine  (AED) have been instru- 
mental  in  elucidating the  specificity and  regulation  of cytotoxic T  lymphocyte 
(CTL)  responses  restricted  by major  histocompatibility  complex  (MHC)  gene 
products  (1-12).  Most  hapten-  (as  well  as  virus)  self CTL  responses  exhibit 
preferential  recognition, that is, the predominant  lytic activity is restricted by a 
single  class  I  product  (3,  4,  9,  13-15).  Although  a  number  of genetic  and 
regulatory mechanisms have been proposed to account for this effect (3, 5,  16- 
18), little biochemical evidence exists that  can explain preferential  recognition 
of certain class I molecules in conjunction with foreign antigens (19). H-2K  k, in 
particular,  is  the  major  restricting  element  for  several  haptens  and  viruses 
including TNP (3, 4), FITC (9), Sendai, and influenza (16, 20, 21). For example 
(17), in the H-2  a hapiotype (Kk/DdLd),  the response against TNP-self is predom- 
inantly directed against KLTNP antigens. 
In  the  present  study  several  anti-MHC  monoclonal  antibodies  (mAb)  have 
been examined for their ability to bind to TNP-modified and unmodified spleen 
cells. The results indicate that certain anti-K k mAb exhibit significantly enhanced 
binding  to TNP-modified,  compared  with  unmodified,  B10.A spleen cells.  In 
addition, anti-K k mAb were shown to specifically bind to TNP-modified, but not 
to  untreated,  allogeneic cells, and  that  cell surface expression  of class I  MHC 
antigens iS required for enhanced binding. These observations suggest that TNP- 
derivatization  of cell  surface  products  can  result  in  the  generation  of neo- 
determinants that resemble alloantigens as detected by serological means. 
Materials and Methods 
Monoclonal Antibodies.  The following rnAb were used in the present study: 36.7.5, anti- 
K  k (22);  I 1.4.1,  anti-K k and cross-reactive  with  K  q'p'r (23); 27.1 I. 13, anti-D b and cross- 
reactive  with D  a'q (24); 28.14.8, anti-D b and cross-reactive  with L  d'q and D  q (24); 100.3, 
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which represents mAb H100-30[3 (25), anti-K  k's, and cross-reactive with r, b, and q, and 
2.4G2, anti-mouse IgG2bFc receptor (Fc~,R) (26). 
Cells.  Spleen cells were isolated from B10 or B10.A mice and treated with either 10 
mM trinitrobenzene sulfonate (TNBS) (Pierce Chemical Co., Rockford, IL) or 0.5 mM 
fluorescein isothiocyanate (FITC)  (Research  Organics,  Cleveland,  OH)  as  previously 
described (3).  The R1  (TL  +) and  R1  (TL-) cell lines were obtained from Dr.  Robert 
Hyman of The Salk Institute, San Diego, CA, and were grown in tissue culture. The R1 
(TL  +) line was  originally derived from a  spontaneous thymoma in a  C58 mouse, and 
expresses the H-2  k haplotype. The R 1 (TL-) variant was obtained by selecting mutagenized 
R 1 (TL  ÷) cells against TL expression. It has concomitantly lost the ability to express MHC 
class  I  molecules, but not other cell surface antigens (27). Cells  from both lines were 
modified with  10  mM  TNBS,  using the  same procedure as for the  spleen cells.  Both 
spleen and lymphoma cells were centrifuged over Lympholyte M (Cedarlane Laboratories, 
Hornby, Ontario) to remove dead cells• 
Radioiodination and Binding  Assay.  The purification and iodination of mAb, and the 
binding assay is described in detail elsewhere (28). Briefly, purified mAb were radiolabeled 
by a modified chloramine T  method (28). Splenic or R1  lymphocytes were iabeledowith 
5*Cr, then mixed with graded concentrations of *~SI-antibody. After incubation at 4  C in 
medium containing 0.2% sodium azide for a time predetermined to allow the system to 
reach equilibrium, the cells were sedimented through a mixture of phthalate oils in 400- 
~zl microfuge tubes (28). The numbers of molecules of  bound antibody/cell were calculated 
1~25  51  from the  I/  Cr ratios in the tips of the microfuge tubes.  Nonsaturable binding was 
determined from controls containing a large excess of unlabeled antibody in addition to 
the  labeled antibody and  cells,  and was  subtracted  from the  total  binding•  Since the 
phthalate oil technique does not require a wash step, it measures both high and low avidity 
•  •  51  mteracuons. In order to assure accurate cell counts of  Cr-labeled ceils, three aliquots of 
the same cell sample were counted microscopically. The resulting values of 51Cr cpm/cell 
were estimated to be accuate to _+ 5%. 
Generation of CTL and Assay for Cytotoxicity Against  TNP-Self  CTL were generated by 
co-culturing mouse spleen cells with autologous spleen cells treated with 10 mM TNBS, 
as previously described (3)• 5 d  later, the resulting effector cells were assayed on 5~Cr- 
labeled TNBS-treated and untreated concanavalin A-stimulated splenic blasts  (3). The 
percentage of lysis and standard error of the mean were calculated based on triplicate 
assay  samples•  Ceils  modified with  FITC  (Sigma  Chemical  Co.,  St.  Louis,  MO)  were 
incubated at 37°C for 15 min at a concentration of 200 ug/ml, as previously described 
(4). 
Results 
Spleen  cells  from  B10.A  mice  modified  with  10  mM  TNBS  or  with  200 
gg/ml FITC were incubated with various concentrations of three different anti- 
K k and  one anti-D  a mAb.  The average numbers  of antibody molecules bound 
per cell were then determined as described in Materials and Methods. The results 
of Fig.  1 A show the binding of 36.7.5 (anti-Kk), to unmodified, TNP-modified, 
or FITC-modified cells. The concentration of haptenic reagents used were those 
typically used to induce cytotoxic T  cell responses.  While 4.4  ×  104 molecules 
per  cell  of  36.7.5  were  bound  to  unmodified  spleen  cells  under  saturating 
conditions, significantly enhanced binding (approximately twofold) was detected 
on cells modified with 10 mM TNBS (Fig.  1A). A similar enhancement of 36.7.5 
binding was  not detected following hapten  modification with  FITC (Fig.  1 A). 
Two additional anti-K  k reagents,  11.4.1  (Fig.  1B) and  100.3  (Fig.  1 C) showed 
similar increases in binding to TNP-modified spleen cells when compared with 
unmodified B10.A spleen cells. To assess whether any anti-class  I  mAb would 
exhibit increased binding after TNBS modification, a  mAb directed against the 1466 
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FIGURE  I.  The binding of radiolabeled antibodies to modified or unmodified BI0.A spleen 
cells plotted on a  linear scale. In panels A-D open triangles indicate binding to unmodified 
cells, open circles to TNP-modified cells, and open squares to FITC-modified ceils. A-C show 
the binding of three different anti-K  k monoclonal antibodies, D shows the binding of 27.11.13, 
an anti-D  d monoclonal antibody, E shows the binding of 36.7.5 (anti-K  k) to (--A--) unmodified 
cells, (---O--) to TNP cells, (- -A- -) to TNP cells in the presence of hapten (0.25 mM DNP- 
e-aminocaproate), and (--I'--) to TNP cells in the presence of 0.8 mg/ml 2.4G2 anti-Fcq~R 
monoclonal antibody; F  shows the binding of rabbit anti-DNP antibodies to (--A--) TNP 
ceils or (--A,--) TNP ceils in the presence of 0.25 mM DNP+aminocaproate. 
D a  molecule  (27.11.13)  was  tested  in  this  system.  In  contrast  to  the  anti-K k 
monoclonals, this antibody bound to similar extents to unmodified, TNP-modi- 
fled, or FITC-modified spleen cells (Fig.  1 D). 
To exclude the possibility that the anti-K k antibodies cross-reacted with TNP, 
36.7.5 was incubated with B 10.A-TNP cells in the presence or absence of 0.25 
mM DNP+aminocaproate  (a high  concentration of inhibitor).  No inhibition  of 
the anti-K k antibody binding  was observed in the presence of the hapten  (Fig. 
1 E).  Free  hapten,  however,  did  inhibit  the  binding  of anti-DNP  antibody  to 
B10.A-TNP cells (Fig.  1F).  Together,  these data indicate  that  the  increase  in 
36.7.5 binding was not the result ofa heteroclitic reaction with TNP. In another 
experiment, spleen cells were treated with a saturating concentration of 2.4G2, 
anti-murine  FcyR mAb (26), to prevent the binding of anti-class I mAb to cells 
by their Fc portions.  The data of Fig.  1 E  demonstrate  that  in this experiment 
~% of the increased binding could have occurred through Fc3,R. 
Our  findings  that  TNP  modification  results  in  enhanced  binding  of anti- 
H-2K  k but not of anti-H-2D  d mAb correlate with the results of studies of CTL 
specificity demonstrating preferential  recognition of K k over D a in responses to 
B 10.A TNP-modified spleen cells (3, 4). When the same B10.A spleen cells used 
for the binding experiments in  Fig.  !  were used to sensitize B10.A spleen cells LEVY  ET  AL.  1467 
against TNP-self (Fig.  2),  a  predominant  Kk-restricted CTL  response was  in- 
duced. Thus, if TNP-modification of B10.A cell surface products results in the 
presence of additional Kk-like determinants, this could contribute to the predom- 
inant K k restriction of anti-TNP self CTL responses. 
Since extensive cross-reactivity has been reported between H-2 alloantigens 
and TNP-self by CTL from H-2  b mice (29-35), we investigated whether anti-K  k 
mAb would recognize TNP-modified B10 cells. The results of Fig. 3A indicate 
that 36.7.5,  which does not bind to unmodified B10  spleen cells, does in fact 
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FIGURE 2.  B10.A  spleen cells were sensitized against autoiogous BI0.A-TNP  stimulating 
cells and assayed against concanavalin A-stimulated, S~Cr-labeled spleen cells: BI0.A-TNP, 
(F'I); B10.BR-TNP  ((3); and B10.D2-TNP  (A). The lysis against unmodified target cells was 
B10.A, 2.7%; BI0.BR, 6.6%; and B10.D2,  1.3%. 
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FIGURE 3.  The binding of radiolabeled monoclonal antibodies to unmodified or modified 
B10 spleen cells. (A). The binding of 36.7.5 (anti-K  k) to (--A--) unmodified BI0 spleen cells, 
(+)  to TNP-modified  B10  spleen  cells, (---0--) to TNP-spleen  cells in  the  presence 
of 0.25  mM  DNP hapten,  and (--A--) to TNP-spleen cells in  the presence of 0.8  mg/ml 
2.4G2 anti-Fc~,R antibody. (B) The binding of 11.4.1  (anti-K  k) to (--A--) unmodified and 
(--O---)  TNP-spleen  cells. IC)The binding of 27.11.13  (anti-D:')a to (--A--)unmodified 
and (----O---) TNP-spleen ce  s. (  ) T  b'nd'ng of 28.14.8 (anti-D L ) to (--A--) unmodified 
and (--O--) TNP spleen cells. 1468  HAPTEN-DEPENDENT  NEO-ALLOANTIGENIC  DETERMINANTS 
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FIGURE 4.  The binding of ~sI-36.7.5 to unmodified or TNP-treated R1 (TL  ÷) and R1 (TL-) 
cells. (A) unmodified R1 (TL+); (O) TNP-modified R1 (TL*);  (ff])  unmodified R1 (TL-); and 
(A) TNP-modified R1 (TL-). The TL  + and TL- cells were treated with the same solution of 
TNBS  and  were both about  equally yellow. The numbers  of TNP molecules]cell were 
estimated by lysing cells in 0.5% NP40 and reading the optical density at 365 nM. By this 
analysis the TNP-R1 (TL  +) had 1.4 x 108 TNP/celI, while the TNP-R1 (TL-) cells had 1.0 x 
10  s TNP/celI. Error bars indicate standard errors from triplicate determinations. 
bind  to  TNP-modified  B10  cells.  Furthermore,  this  binding  activity  was  not 
inhibited by free hapten, nor by the anti-Fc~,R monoclonal antibody 2.4G2 (26), 
demonstrating that 36.7.5 does not bind to TNP or Fc3,R on the modified B 10 
cells. A  second anti-K  k mAb,  11.4.1, which failed to react with B10 spleen cells, 
also  bound  significantly  to  TNP-modified  B10  cells  (Fig.  3/3).  However,  two 
mAb directed against D b antigens, 27.11.13 and 28.14.8, failed to show increased 
binding to B 10 cells after TNP modification (Fig. 3, C and D). Although we have 
not made an extensive survey of the binding of 36.7.5  to TNP-modified spleen 
cells of various haplotypes, we have observed that  TNP-modified ATL  spleen 
cells and TNP-B10 cells (data not shown) bind 36.7.5 to a similar extent. This is 
of interest because the 36.7.5 antibody was derived from ATL spleen cells (i.e., 
ATL anti-AAL). 
To determine whether the enhanced binding of anti-K  k mAb by TNP-modified 
cells was dependent on expression of class I  MHC molecules, the R1  (TL  +) and 
R1  (TL-) cell lines were modified with TNP and tested for 36.7.5  binding.  As 
shown  in  Fig.  4,  36.7.5  bound  saturably  to  the  TL  +  cell  line  and  exhibited 
enhanced  binding  to  TNP-modified  R1  (TL+).  In  contrast,  the  TL-  line,  a 
variant that does not express class I  molecules (27), did not bind 36.7.5, either 
unmodified or when modified with TNP. These data indicate that class I  MHC 
molecules are  required  to  obtain  enhanced  binding  of anti-K  k mAb  to  TNP- 
modified H-2 k cells. 
Discussion 
The data presented in this study demonstrate that modification of cell surface 
products with  TNP  can  result  in  the formation of neooantigenic determinants 
that mimic H-2K  k epitopes in their ability to bind anti-K  k mAb.  The enhanced 
binding ofanti-K  k mAb to TNP-modified cells is not due to a heteroclitic reaction 
with the TNP  groups,  since binding is not blocked by free hapten (Figs.  1 and LEVY  ET  AL.  1469 
3).  Furthermore, it is highly unlikely that  three different anti-K  k mAb would 
each cross-react with  some neo-determinant structurally distinct from the  K  k 
epitope to which it was raised. Rather, the simplest and most likely interpretation 
of the data is that the neo-determinants that are produced by TNP modification 
of B 10 and B 10.A spleen cells are structurally similar to K  k epitopes. 
The cross-reactivity of the anti-K  k mAb with TNP-modified B10 cells (Fig. 3) 
parallels the well-established cross-reaction that CTL raised against allogeneic 
stimulators exhibit when tested against TNP-self, especially in the B10  strain 
(29). It has also been demonstrated, both in bulk cultures (34) and at the clonal 
level (33), that B10 spleen cells stimulated with B10-TNP can lyse unmodified 
H-2 k targets. The similarities in the cross-reactions exhibited by both CTL and 
antibodies suggest that the CTL may recognize the same neo-antigens that are 
detected by the mAb. 
The nature of the neo-determinants is unknown, although the data of Fig. 4 
suggest that they require the expression of MHC class I molecules, since these 
neo-determinants were not detected on the TNP-modified class I negative variant 
line. One possibility is that the neo-antigens arise from TNP modification of class 
I molecules themselves. TNP derivatization of these products has been shown to 
occur (36), and since considerable homology between class I allelic products has 
been demonstrated (37), subtle modification of H-2  b MHC products might result 
in  the  formation of Kk-like  determinants.  Alternatively, TNP-modified non- 
class I  molecules might interact on the cell surface with class  I  molecules and 
induce a  change in epitope expression. This latter hypothesis is perhaps more 
attractive, since it provides a  molecular basis for the function of MHC class  I 
antigens,  namely to  serve as  signal proteins that  CTL  could utilize to  detect 
changes in cell surfaces resulting from, for example, viral infection. 
We do not yet know whether the appearance of neo-determinants occurs only 
with TNP  modification, or is a  more general phenomenon that could involve 
other haptens or viruses. Some studies have reported that vitally infected murine 
(38) and human (39) cells can bind alloantibodies, while other studies (32) have 
shown that CTL raised against virally infected self can cross-react with uninfected 
allogeneic cells. Recently it has been reported that neo-antigens that resemble 
HLA allodeterminants can be detected with mAb when human leukocytes are 
infected with human T  cell leukemia virus (40).  Finally, it has also been found 
(41) that a majority of mAb raised against virally infected syngeneic cells would 
not bind to either the virus alone or to uninfected syngeneic cells, but would 
react with infected cells. One explanation of these results is that the cell surface 
modifications resulting from viral infection included the production of class I- 
like neo-antigenic determinants, and that the mAb were directed against these 
determinants. It would be interesting to know whether such antibodies would 
bind to uninfected allogeneic cells. 
The approach used in the present study may be valuable in elucidating the 
structural changes that can occur when class I  molecules interact with foreign 
antigens on cell surfaces.  Our  data are consistent with  the idea that antigen- 
induced altered regions on class I molecules serve as recognition sites for CTL 
and determine whether or not lysis will occur. 1470  HAPTEN-DEPENDENT  NEO-ALLOANTIGENIC DETERMINANTS 
Summary 
Several anti-H-2K  k but not anti-H-2D  d monoclonal antibodies (mAb) exhib- 
ited enhanced binding to  B 10.A  murine spleen cells after modification of the 
cells with trinitrobenzene sulfonate (TNBS). The number of antibody molecules 
bound to TNP-modified B 10.A spleen cells increased by a factor of two or more. 
The  same anti-2K  k mAb  that exhibited enhanced binding to  modified B10.A 
cells did not bind to unmodified C57BL/10  spleen cells, as expected, but did 
bind  to  TNP-modified  C57BL/10  spleen  cells.  This  TNP-dependent  binding 
was not a  result of cross-reactions  with cell  surface TNP  groups  nor with  Fc 
receptors.  TNP modification of a  variant cell line that does not express class I 
H-2 products did not result in enhanced binding by these mAb. These findings 
can account for preferential recognition of TNP-K  k by B10.A and B 10.BR CTL, 
and also  for cross-reactive  lysis by C57BL/10  CTL stimulated by C57BL/10- 
TNP against unmodified H-2K  k targets. 
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